Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning.
Glucose metabolism
Microglia
P301S
PET
Spatial learning
TSPO
Tau
Journal
Journal of neuroinflammation
ISSN: 1742-2094
Titre abrégé: J Neuroinflammation
Pays: England
ID NLM: 101222974
Informations de publication
Date de publication:
13 Jul 2020
13 Jul 2020
Historique:
received:
16
03
2020
accepted:
30
06
2020
entrez:
15
7
2020
pubmed:
15
7
2020
medline:
25
5
2021
Statut:
epublish
Résumé
P301S tau transgenic mice show age-dependent accumulation of neurofibrillary tangles in the brainstem, hippocampus, and neocortex, leading to neuronal loss and cognitive deterioration. However, there is hitherto only sparse documentation of the role of neuroinflammation in tau mouse models. Thus, we analyzed longitudinal microglial activation by small animal 18 kDa translocator protein positron-emission-tomography (TSPO μPET) imaging in vivo, in conjunction with terminal assessment of tau pathology, spatial learning, and cerebral glucose metabolism. Transgenic P301S (n = 33) and wild-type (n = 18) female mice were imaged by TSPO expression in all target regions of P301S mice increased exponentially from 1.9 to 6.4 months, leading to significant differences in the contrasts with wild-type mice at 6.4 months (+ 11-23%, all p < 0.001), but the apparent microgliosis proceeded more slowly than in our experience in amyloid-β mouse models. Spatial learning and glucose metabolism of AT8-positive P301S mice were significantly impaired at 6.3-6.5 months compared to the wild-type group. Longitudinal increases in TSPO expression predicted greater tau accumulation and lesser spatial learning performance at 6.3-6.7 months. Monitoring of TSPO expression as a surrogate of microglial activation in P301S tau transgenic mice by μPET indicates a delayed time course when compared to amyloid-β mouse models. Detrimental associations of microglial activation with outcome parameters are opposite to earlier data in amyloid-β mouse models. The contribution of microglial response to pathology accompanying amyloid-β and tau over-expression merits further investigation.
Sections du résumé
BACKGROUND
BACKGROUND
P301S tau transgenic mice show age-dependent accumulation of neurofibrillary tangles in the brainstem, hippocampus, and neocortex, leading to neuronal loss and cognitive deterioration. However, there is hitherto only sparse documentation of the role of neuroinflammation in tau mouse models. Thus, we analyzed longitudinal microglial activation by small animal 18 kDa translocator protein positron-emission-tomography (TSPO μPET) imaging in vivo, in conjunction with terminal assessment of tau pathology, spatial learning, and cerebral glucose metabolism.
METHODS
METHODS
Transgenic P301S (n = 33) and wild-type (n = 18) female mice were imaged by
RESULTS
RESULTS
TSPO expression in all target regions of P301S mice increased exponentially from 1.9 to 6.4 months, leading to significant differences in the contrasts with wild-type mice at 6.4 months (+ 11-23%, all p < 0.001), but the apparent microgliosis proceeded more slowly than in our experience in amyloid-β mouse models. Spatial learning and glucose metabolism of AT8-positive P301S mice were significantly impaired at 6.3-6.5 months compared to the wild-type group. Longitudinal increases in TSPO expression predicted greater tau accumulation and lesser spatial learning performance at 6.3-6.7 months.
CONCLUSIONS
CONCLUSIONS
Monitoring of TSPO expression as a surrogate of microglial activation in P301S tau transgenic mice by μPET indicates a delayed time course when compared to amyloid-β mouse models. Detrimental associations of microglial activation with outcome parameters are opposite to earlier data in amyloid-β mouse models. The contribution of microglial response to pathology accompanying amyloid-β and tau over-expression merits further investigation.
Identifiants
pubmed: 32660586
doi: 10.1186/s12974-020-01883-5
pii: 10.1186/s12974-020-01883-5
pmc: PMC7358201
doi:
Substances chimiques
Bzrp protein, mouse
0
Receptors, GABA
0
tau Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
208Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : BR4580/1-1
Organisme : Deutsche Forschungsgemeinschaft
ID : RO5194/1-1
Organisme : Deutsche Forschungsgemeinschaft
ID : EXC 2145 SyNergy - ID 390857198
Références
JAMA Neurol. 2017 Dec 1;74(12):1464-1472
pubmed: 29059326
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006189
pubmed: 22229116
Nature. 2019 Nov;575(7784):669-673
pubmed: 31748742
Cell Rep. 2018 Aug 21;24(8):1939-1948.e4
pubmed: 30134156
J Neurosci. 2002 Nov 1;22(21):9340-51
pubmed: 12417659
J Nucl Med. 2016 Jun;57(6):954-60
pubmed: 26912428
J Neurosci. 2011 Mar 23;31(12):4720-30
pubmed: 21430171
J Neurochem. 2019 May;149(4):438-451
pubmed: 30339715
J Nucl Med. 2019 Apr;60(4):548-554
pubmed: 30262517
J Nucl Med. 2016 May;57(5):792-8
pubmed: 26912432
J Alzheimers Dis. 2018;61(3):1037-1052
pubmed: 29332041
Lancet Neurol. 2013 Jun;12(6):609-22
pubmed: 23684085
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Mol Neurodegener. 2017 Jun 29;12(1):50
pubmed: 28662669
Mol Psychiatry. 2020 Feb;25(2):351-367
pubmed: 31772305
J Neurosci. 2015 Nov 25;35(47):15716-30
pubmed: 26609163
J Nucl Med. 2017 Dec;58(12):1984-1990
pubmed: 28705919
Neuropathol Appl Neurobiol. 2014 Dec;40(7):833-43
pubmed: 24865638
Nat Neurosci. 2019 Feb;22(2):191-204
pubmed: 30617257
Neurobiol Dis. 2009 Jan;33(1):20-7
pubmed: 18930824
Front Neurol. 2018 Aug 07;9:625
pubmed: 30131755
Nature. 2018 Oct;562(7728):578-582
pubmed: 30232451
Neuroimage. 2018 Jan 15;165:83-91
pubmed: 28988133
Sci Rep. 2015 Jun 09;5:11161
pubmed: 26057852
Am J Pathol. 2004 Nov;165(5):1643-52
pubmed: 15509534
J Alzheimers Dis. 2018;64(s1):S339-S351
pubmed: 29865053
Brain. 2017 Mar 1;140(3):792-803
pubmed: 28122877
J Nucl Med. 2019 Dec;60(12):1787-1793
pubmed: 31302633
Neuron. 2007 Feb 1;53(3):337-51
pubmed: 17270732
J Neuroinflammation. 2018 Nov 6;15(1):307
pubmed: 30400912
Exp Gerontol. 2017 Aug;94:103-107
pubmed: 27979768
Brain. 2018 Sep 1;141(9):2740-2754
pubmed: 30052812